ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MBIO Mustang Bio Inc

0,2797
0,0196 (7,54%)
Nach Börsenschluss
Zuletzt aktualisiert: 01:11:48
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Mustang Bio Inc MBIO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,0196 7,54% 0,2797 01:11:48
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,2699 0,2699 0,2999 0,293 0,2601
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
30.4.202402:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
28.3.202414:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
11.3.202421:30EDGAR2Form 8-K - Current report
11.3.202421:05GLOBEMustang Bio Reports Full-Year 2023 Financial Results and..
11.3.202421:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07.3.202413:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
14.2.202422:15EDGAR2Form 8-K - Current report
25.1.202422:07EDGAR2Form 8-K - Current report
11.1.202414:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
04.1.202422:05EDGAR2Form 8-K - Current report
19.12.202322:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12.12.202303:52EDGAR2Form S-1 - General form for registration of securities under..
11.12.202314:37EDGAR2Form 8-K - Current report
11.12.202314:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
14.11.202322:44EDGAR2Form 8-K - Current report
14.11.202322:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
03.11.202320:22EDGAR2Form D - Notice of Exempt Offering of Securities
02.11.202321:05EDGAR2Form 8-K - Current report
02.11.202314:28GLOBEMustang Bio Announces MB-106 CD20-Targeted CAR-T Data..
30.10.202319:57EDGAR2Form 8-K - Current report
30.10.202319:15GLOBEMustang Bio Announces Closing of $4.4 Million Registered..
30.10.202315:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26.10.202322:05EDGAR2Form 8-K - Current report
26.10.202318:30GLOBEMustang Bio Announces $4.4 Million Registered Direct..
26.10.202315:00GLOBEMustang Bio Announces FDA Acceptance of IND Application for..
04.10.202322:05EDGAR2Form 8-K - Current report
16.8.202314:56EDGAR2Form 8-K - Current report
14.8.202322:10EDGAR2Form 8-K - Current report
14.8.202322:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
14.8.202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.7.202314:40EDGAR2Form 8-K - Current report
20.7.202323:30EDGAR2Form 8-K - Current report
11.7.202314:05EDGAR2Form 8-K - Current report
07.7.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.6.202314:05EDGAR2Form 8-K - Current report
15.5.202322:01GLOBEFortress Biotech Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock